Lexaria Bioscience Insider Trades

LEXX

Track insider trading activity from Lexaria Bioscience executives and directors. See which insiders are buying and selling LEXX stock.

Trades Last 12 Months

LEXX Price

All Insider Trades for Lexaria Bioscience

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $169k 273,543 shares
Last Trade
Mar 17, 2026 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$73.2k 100,000 shares
$0.73
$0.62
Holding Value $11.3k 18,191 shares
Last Trade
Jul 29, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.55k 5,000 shares
$0.91
$0.62
Carle Vanessa Secretary
Holding Value $465 750 shares
Last Trade
Jul 29, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$683 750 shares
$0.91
$0.62
Christopher Richard Chief Executive Officer
Holding Value $40.3k 65,000 shares
Last Trade
Jul 29, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$13.7k 15,000 shares
$0.91
$0.62
Docherty John Martin President & CSO
Holding Value $3.33k 5,376 shares
Last Trade
Jul 29, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5k 5,376 shares
$0.93
$0.62
Holding Value $26.6k 43,000 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.4k 11,000 shares
$1.04
$0.62
Holding Value $6.82k 11,000 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.4k 11,000 shares
$1.04
$0.62
Holding Value $39k 63,000 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.4k 11,000 shares
$1.04
$0.62
Shankman Michael Elliot Chief Financial Officer
Holding Value $62k 100,000 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52k 50,000 shares
$1.04
$0.62
Holding Value $1.92k 3,100 shares
Last Trade
Aug 12, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$5.01k 1,600 shares
$3.13
$0.62
Cabatuan Nelson Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 15, 2024 Sale
$780k 200,000 shares
$3.90
$0.62
Downey Gregory Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Apr 15, 2023 Sale
$8.72k 4,000 shares
$2.18
$0.62
Holding Value $5.2k 8,400 shares
Last Trade
Sep 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.8k 1,900 shares
$6.23
$0.62
Quigley Brian W. Director
Holding Value $62k 100,000 shares
Last Trade
Apr 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.8k 100,000 shares
$0.26
$0.62
Spissinger Allan Horst Chief Financial Officer
Holding Value $403k 650,000 shares
Last Trade
Apr 23, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$168k 650,000 shares
$0.26
$0.62
Demartini David Director
Holding Value $62k 100,000 shares
Last Trade
Jun 18, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.5k 50,000 shares
$0.05
$0.62
Holding Value $0 0 shares
Last Trade
Jul 08, 2011 Sale
$45k 150,000 shares
$0.30
$0.62
Ihrke Thomas James Sr. Vp, Business Developement
Holding Value $155k 250,385 shares
Last Trade
Dec 22, 2010 Sale (Open Market)Shares sold on the open market or in a private sale.
$217 700 shares
$0.31
$0.62

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up